drugset / Trial / NCT05855590

Tranexamic Acid in Debridement Surgery of Burns on the Volume of Bleeding in Transfusion Requirements

NCT05855590

Phase 3 Unknown 20 enrolled Mexican Social Security Institute
RandomizedFactorialDouble-blindTreatment

Summary

Tranexamic acid in debridement surgery of burns on the volume of bleeding in transfusion requirements

Timeline

Start
2022-01-01
Primary completion
2022-01-01
Completion
2023-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 10 mg/kg Intravenous

Indications

No indication recorded.